Data / Form D filings / Avstera Therapeutics Corp.
Avstera Therapeutics Corp.: Form D filings
Avstera Therapeutics Corp., a biotechnology company in Malvern, PA, filed 3 Form D notices with the SEC between 2021 and 2023. The latest, on October 3, 2023, reports $5 million sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 365 PHOENIXVILLE PIKE, Malvern, PA, 19355
- Phone
- (267) 925-0454
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1878281
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 3, 2023 | New notice | $5,000,000 | $5,000,000 | 1 | Sep 19, 2023 | sec.gov | |
| May 20, 2022 | New notice | $6,000,000 | $3,500,000 | $2,500,000 | 3 | May 6, 2022 | sec.gov |
| Aug 12, 2021 | New notice | Indefinite | $100,000 | 1 | Jul 21, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ajay Raju | Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Oct 2, 2023 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Avstera Therapeutics Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.